<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html><head><title>Patent US5916912 - Orally administering to the host an effective dosage of a carnitine, such as ... - Google Patents</title><script>(function(){(function(){function e(a){this.t={};this.tick=function(a,c,b){var d=void 0!=b?b:(new Date).getTime();this.t[a]=[d,c];if(void 0==b)try{window.console.timeStamp("CSI/"+a)}catch(e){}};this.tick("start",null,a)}var a;window.performance&&(a=window.performance.timing);var f=a?new e(a.responseStart):new e;window.jstiming={Timer:e,load:f};if(a){var c=a.navigationStart,d=a.responseStart;0<c&&d>=c&&(window.jstiming.srt=d-c)}if(a){var b=window.jstiming.load;0<c&&d>=c&&(b.tick("_wtsrt",void 0,c),b.tick("wtsrt_",
"_wtsrt",d),b.tick("tbsd_","wtsrt_"))}try{a=null,window.chrome&&window.chrome.csi&&(a=Math.floor(window.chrome.csi().pageT),b&&0<c&&(b.tick("_tbnd",void 0,window.chrome.csi().startE),b.tick("tbnd_","_tbnd",c))),null==a&&window.gtbExternal&&(a=window.gtbExternal.pageT()),null==a&&window.external&&(a=window.external.pageT,b&&0<c&&(b.tick("_tbnd",void 0,window.external.startE),b.tick("tbnd_","_tbnd",c))),a&&(window.jstiming.pt=a)}catch(g){}})();})();
</script><link rel="stylesheet" href="/patents/css/_8a2b04e7bf975d5171d8e4c0b6365c7a/kl_intl_patents_bundle.css" type="text/css" /><script src="/books/javascript/atb_8a2b04e7bf975d5171d8e4c0b6365c7a__en.js"></script><script>function googleTranslateElementInit() {new google.translate.TranslateElement({pageLanguage: "en",gaTrack: true,gaId: "UA-27188110-1",multilanguagePage: true});}</script><script src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><meta name="DC.type" content="Patent"><meta name="DC.title" content="Orally administering to the host an effective dosage of a carnitine, such as acetyl-l-carnitine, and a mitochondrially active antioxidant, such as lipoic acid; restores mitochondiral functions; mitigation of indicia of aging"><meta name="DC.contributor" content="Bruce N. Ames" scheme="inventor"><meta name="DC.contributor" content="Tory M. Hagen" scheme="inventor"><meta name="DC.contributor" content="The Regents Of The University Of California" scheme="assignee"><meta name="DC.date" content="1997-6-16" scheme="dateSubmitted"><meta name="DC.description" content="The metabolic rate of aged cells of a mammalian host is enhanced without a concomitant increase in metabolic production of reactive oxygen species by orally administering to the host an effective dosage of a carnitine, such as acetyl-L-carnitine, and a mitochondrially active antioxidant, such as lipoic acid."><meta name="DC.date" content="1999-6-29" scheme="issued"><meta name="DC.relation" content="US:4599232" scheme="references"><meta name="DC.relation" content="US:5292538" scheme="references"><meta name="DC.relation" content="US:5560928" scheme="references"><meta name="citation_reference" content="Medical Hypotheses, McCarty; vol. 7, pp. 520 521, 1981."><meta name="citation_reference" content="Medical Hypotheses, McCarty; vol. 7, pp. 520-521, 1981."><meta name="citation_patent_number" content="US:5916912"><meta name="citation_patent_application_number" content="US:08/874,467"><link rel="canonical" href="http://www.google.com/patents/US5916912"/><meta property="og:url" content="http://www.google.com/patents/US5916912"/><meta name="title" content="Patent US5916912 - Orally administering to the host an effective dosage of a carnitine, such as acetyl-l-carnitine, and a mitochondrially active antioxidant, such as lipoic acid; restores mitochondiral functions; mitigation of indicia of aging"/><meta name="description" content="The metabolic rate of aged cells of a mammalian host is enhanced without a concomitant increase in metabolic production of reactive oxygen species by orally administering to the host an effective dosage of a carnitine, such as acetyl-L-carnitine, and a mitochondrially active antioxidant, such as lipoic acid."/><meta property="og:title" content="Patent US5916912 - Orally administering to the host an effective dosage of a carnitine, such as acetyl-l-carnitine, and a mitochondrially active antioxidant, such as lipoic acid; restores mitochondiral functions; mitigation of indicia of aging"/><meta property="og:type" content="book"/><meta property="og:site_name" content="Google Books"/><meta property="og:image" content="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><link rel="image_src" href="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><script>(function(){try{var aa=function(a,b,c,d){d=d||{};d._sn=["cfg",b,c].join(".");window.gbar.logger.ml(a,d)};var g=window.gbar=window.gbar||{},l=window.gbar.i=window.gbar.i||{},m={},n;function _tvn(a,b){var c=parseInt(a,10);return isNaN(c)?b:c}function _tvf(a,b){var c=parseFloat(a);return isNaN(c)?b:c}function _tvv(a){return!!a}function p(a,b,c){(c||g)[a]=b}g.bv={n:_tvn("2",0),r:"",f:".67.",e:"0",m:_tvn("0",1)};
function q(a,b,c){var d="on"+b;if(a.addEventListener)a.addEventListener(b,c,!1);else if(a.attachEvent)a.attachEvent(d,c);else{var f=a[d];a[d]=function(){var a=f.apply(this,arguments),b=c.apply(this,arguments);return void 0==a?b:void 0==b?a:b&&a}}}var s=function(a){return function(){return g.bv.m==a}},ba=s(1),ca=s(2);p("sb",ba);p("kn",ca);l.a=_tvv;l.b=_tvf;l.c=_tvn;l.i=aa;var da=window.gbar.i.i;var t,u,v,w;function ea(a){v=a}function fa(a){var b;if(b=v&&window.encodeURIComponent)b=a.href,b=!b.match(/^http[s]?:\/\/accounts\.google\.[^/]*\/ClearSID/i)&&!b.match(/^http[s]?:\/\/[^/]*\/accounts\/ClearSID/i);if(b=b&&encodeURIComponent(v()))a.href=a.href.replace(/([?&]continue=)[^&]*/,"$1"+b)}function ga(a){window.gApplication&&(a.href=window.gApplication.getTabUrl(a.href))}
function ha(a){var b=document.forms[0].q,c=window.encodeURIComponent&&b&&b.value,b=b&&b.placeholder;c&&c!=b&&(a.href=a.href.replace(/([?&])q=[^&]*|$/,function(a,b){return(b||"&")+"q="+encodeURIComponent(c)}))}n=l.a("")?ga:ha;
function x(a,b,c,d,f,e){var h=document.getElementById(a);if(h){var k=h.style;k.left=d?"auto":b+"px";k.right=d?b+"px":"auto";k.top=c+"px";k.visibility=u?"hidden":"visible";f&&e?(k.width=f+"px",k.height=e+"px"):(x(t,b,c,d,h.offsetWidth,h.offsetHeight),u=u?"":a)}}
var y=[],ia=function(a,b){y.push(b)},ja=function(a){a=a||window.event;var b=a.target||a.srcElement;a.cancelBubble=!0;null==t&&(a=document.createElement(Array.every||window.createPopup?"iframe":"div"),a.frameBorder="0",t=a.id="gbs",a.src="javascript:''",b.parentNode.appendChild(a),q(document,"click",z));var c=b,b=0;"gb3"!=c.className&&(c=c.parentNode);a=c.getAttribute("aria-owns")||"gbi";var d=c.offsetWidth,f=20<c.offsetTop?46:24;document.getElementById("tphdr")&&(f-=3);var e=!1;do b+=c.offsetLeft||
0;while(c=c.offsetParent);var c=(document.documentElement.clientWidth||document.body.clientWidth)-b-d,h,d=document.body,k=document.defaultView;k&&k.getComputedStyle?(d=k.getComputedStyle(d,""))&&(h=d.direction):h=d.currentStyle?d.currentStyle.direction:d.style.direction;h="rtl"==h;if("gbi"==a){for(d=0;k=y[d++];)k();A(null,window.navExtra);h&&(b=c,e=!0)}else h||(b=c,e=!0);u!=a&&z();x(a,b,f,e)},z=function(){u&&x(u,0,0)},A=function(a,b){var c,d=document.getElementById("gbi"),f=a;f||(f=d.firstChild);
for(;b&&(c=b.pop());){var e=d,h=c,k=f;w||(w="gb2");e.insertBefore(h,k).className=w}},ka=function(a,b,c){if((b=document.getElementById(b))&&a){a.className="gb4";var d=document.createElement("span");d.appendChild(a);d.appendChild(document.createTextNode(" | "));d.id=c;b.appendChild(d)}},la=function(){return document.getElementById("gb_70")},ma=function(){return!!u};p("qs",n);p("setContinueCb",ea);p("pc",fa);p("tg",ja);p("close",z);p("addLink",ka);p("almm",A);p("si",la);p("adh",ia);p("op",ma);var B=function(){},C=function(){},F=function(a){var b=new Image,c=D;b.onerror=b.onload=b.onabort=function(){try{delete E[c]}catch(a){}};E[c]=b;b.src=a;D=c+1},E=[],D=0;p("logger",{il:C,ml:B,log:F});var G=window.gbar.logger;var H={},na={},I=[],oa=l.b("0.1",.1),pa=l.a("1",!0),qa=function(a,b){I.push([a,b])},ra=function(a,b){H[a]=b},sa=function(a){return a in H},J={},K=function(a,b){J[a]||(J[a]=[]);J[a].push(b)},ta=function(a){K("m",a)},L=function(a,b){var c=document.createElement("script");c.src=a;c.async=pa;Math.random()<oa&&(c.onerror=function(){c.onerror=null;B(Error("Bundle load failed: name="+(b||"UNK")+" url="+a))});(document.getElementById("xjsc")||document.getElementsByTagName("body")[0]||
document.getElementsByTagName("head")[0]).appendChild(c)},N=function(a){for(var b=0,c;(c=I[b])&&c[0]!=a;++b);!c||c[1].l||c[1].s||(c[1].s=!0,M(2,a),c[1].url&&L(c[1].url,a),c[1].libs&&m.d&&m.d(c[1].libs))},O=function(a){K("gc",a)},P=null,ua=function(a){P=a},M=function(a,b,c){if(P){a={t:a,b:b};if(c)for(var d in c)a[d]=c[d];try{P(a)}catch(f){}}};p("mdc",H);p("mdi",na);p("bnc",I);p("qGC",O);p("qm",ta);p("qd",J);p("lb",N);p("mcf",ra);p("bcf",qa);p("aq",K);p("mdd","");p("has",sa);
p("trh",ua);p("tev",M);var Q=l.b("0.1",.001),R=0;
function _mlToken(a,b){try{if(1>R){R++;var c,d=a,f=b||{},e=encodeURIComponent,h=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&jexpid=",e("17483"),"&srcpg=",e("prop=22"),"&jsr=",Math.round(1/Q),"&ogev=",e("u1fsU5z-F7KssQThoIDYDA"),"&ogf=",g.bv.f,"&ogrp=",e("1"),"&ogv=",e("1407723702.0"),"&oggv="+e("es_plusone_gc_20140723.0_p0"),"&ogd=",e("com"),"&ogc=",e("USA"),"&ogl=",e("en")];f._sn&&(f._sn="og."+
f._sn);for(var k in f)h.push("&"),h.push(e(k)),h.push("="),h.push(e(f[k]));h.push("&emsg=");h.push(e(d.name+":"+d.message));var r=h.join("");S(r)&&(r=r.substr(0,2E3));c=r;var Aa=window.gbar.logger._aem(a,c);F(Aa)}}catch(Na){}}var S=function(a){return 2E3<=a.length},va=function(a,b){return b};function T(a){B=a;p("_itl",S,G);p("_aem",va,G);p("ml",B,G);a={};H.er=a}l.a("")?T(function(a){throw a;}):l.a("1")&&Math.random()<Q&&T(_mlToken);I.push(["m",{url:"//ssl.gstatic.com/gb/js/scm_7385cc5883250b43a39405734c1bea59.js"}]);g.mcf("c",{});g.sg={c:""};if(l.a("1")){var wa=l.a("");I.push(["gc",{auto:wa,url:"//ssl.gstatic.com/gb/js/abc/gci_91f30755d6a6b787dcc2a4062e6e9824.js",libs:"googleapis.client:plusone:gapi.iframes"}]);var xa={version:"gci_91f30755d6a6b787dcc2a4062e6e9824.js",index:"",lang:"en"};H.gc=xa;var U=function(a){window.googleapis&&window.iframes?a&&a():(a&&O(a),N("gc"))};p("lGC",U);l.a("1")&&p("lPWF",U)};window.__PVT="";if(l.a("1")&&l.a("1")){var V=function(a){U(function(){K("pw",a);N("pw")})};p("lPW",V);I.push(["pw",{url:"//ssl.gstatic.com/gb/js/abc/pwm_45f73e4df07a0e388b0fa1f3d30e7280.js"}]);var W=[],ya=function(a){W[0]=a},za=function(a,b){var c=b||{};c._sn="pw";B(a,c)},Ba={signed:W,elog:za,base:"https://plusone.google.com/u/0",loadTime:(new Date).getTime()};H.pw=Ba;var X=function(a,b){for(var c=b.split("."),d=function(){var b=arguments;a(function(){for(var a=g,d=0,e=c.length-1;d<e;++d)a=a[c[d]];a[c[d]].apply(a,b)})},f=g,e=0,h=c.length-1;e<h;++e)f=
f[c[e]]=f[c[e]]||{};return f[c[e]]=d};X(V,"pw.clk");X(V,"pw.hvr");p("su",ya,g.pw)};function Ca(){function a(){for(var b;(b=e[h++])&&"m"!=b[0]&&!b[1].auto;);b&&(M(2,b[0]),b[1].url&&L(b[1].url,b[0]),b[1].libs&&m.d&&m.d(b[1].libs));h<e.length&&setTimeout(a,0)}function b(){0<f--?setTimeout(b,0):a()}var c=l.a("1"),d=l.a(""),f=3,e=I,h=0,k=window.gbarOnReady;if(k)try{k()}catch(r){da(r,"ml","or")}d?p("ldb",a):c?q(window,"load",b):b()}p("rdl",Ca);var Da={D:1,H:2,da:3,p:4,W:5,M:6,F:7,g:8,ha:9,U:10,L:11,T:12,S:13,N:14,Q:15,P:16,fa:17,w:18,O:19,ga:20,ea:21,u:22,G:23,ja:24,ka:25,ia:26,A:27,j:28,o:29,k:30,ca:31,Z:32,$:33,J:34,K:35,ba:36,aa:37,Y:38,B:39,R:40,v:41,X:42,V:43,h:48,C:49,I:500},Y=[1,2,3,4,5,6,9,10,11,13,14,28,29,30,34,35,37,38,39,40,41,42,43,48,49,500];var Z=l.b("0.001",1E-4),Ea=l.b("1",1),Fa=!1,Ga=!1;if(l.a("1")){var Ha=Math.random();Ha<=Z&&(Fa=!0);Ha<=Ea&&(Ga=!0)}var Ia=Da,$=null;function Ja(){var a=0,b=function(b,d){l.a(d)&&(a|=b)};b(1,"");b(2,"");b(4,"");b(8,"");return a}
function Ka(a,b){var c=Z,d=Fa,f;f=a;if(!$){$={};for(var e=0;e<Y.length;e++){var h=Y[e];$[h]=!0}}if(f=!!$[f])c=Ea,d=Ga;if(d){d=encodeURIComponent;g.rp?(f=g.rp(),f="-1"!=f?f:"1"):f="1";c=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&oge=",a,"&ogex=",d("17483"),"&ogev=",d("u1fsU5z-F7KssQThoIDYDA"),"&ogf=",g.bv.f,"&ogp=",d("22"),"&ogrp=",d(f),"&ogsr=",Math.round(1/c),"&ogv=",d("1407723702.0"),"&oggv="+
d("es_plusone_gc_20140723.0_p0"),"&ogd=",d("com"),"&ogl=",d("en"),"&ogc=",d("USA"),"&ogus=",Ja()];if(b){"ogw"in b&&(c.push("&ogw="+b.ogw),delete b.ogw);var k;f=b;e=[];for(k in f)0!=e.length&&e.push(","),e.push(La(k)),e.push("."),e.push(La(f[k]));k=e.join("");""!=k&&(c.push("&ogad="),c.push(d(k)))}F(c.join(""))}}function La(a){"number"==typeof a&&(a+="");return"string"==typeof a?a.replace(".","%2E").replace(",","%2C"):a}C=Ka;p("il",C,G);var Ma={};H.il=Ma;setTimeout(function(){C(Ia.g)},0);}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var b=window.gbar.i.i;var c=window.gbar;var f=function(d){try{var a=document.getElementById("gbom");a&&d.appendChild(a.cloneNode(!0))}catch(e){b(e,"omas","aomc")}};c.aomc=f;}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var a=window.gbar;a.mcf("pm",{p:""});}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{window.gbar.rdl();}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
if (window['_OC_timingAction']) {window['_OC_timingAction']('patents_refpage');}</script><style>#gbar,#guser{font-size:13px;padding-top:1px !important;}#gbar{float:left;height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}#gbs,.gbm{background:#fff;left:0;position:absolute;text-align:left;visibility:hidden;z-index:1000}.gbm{border:1px solid;border-color:#c9d7f1 #36c #36c #a2bae7;z-index:1001}.gb1{margin-right:.5em}.gb1,.gb3{zoom:1}.gb2{display:block;padding:.2em .5em}.gb2,.gb3{text-decoration:none !important;border-bottom:none}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb2,a.gb3,a.gb4{color:#00c !important}.gbi .gb3,.gbi .gb2,.gbi .gb4{color:#dd8e27 !important}.gbf .gb3,.gbf .gb2,.gbf .gb4{color:#900 !important}a.gb2:hover{background:#36c;color:#fff !important}#gbar .gbz0l{color:#000 !important;cursor:default;font-weight:bold;text-decoration:none !important}
#gbar { padding:.3em .6em !important;}</style></head><body  topmargin="3" marginheight="3"><div id=gbar><nobr><a onclick=gbar.qs(this);gbar.logger.il(1,{t:1}); class=gb1 id=gb_1 href="https://www.google.com/search?sa=N&tab=tw">Search</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:2}); class=gb1 id=gb_2 href="http://www.google.com/search?hl=en&tbm=isch&source=og&sa=N&tab=ti">Images</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:8}); class=gb1 id=gb_8 href="http://maps.google.com/maps?hl=en&sa=N&tab=tl">Maps</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:78}); class=gb1 id=gb_78 href="https://play.google.com/?hl=en&sa=N&tab=t8">Play</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:36}); class=gb1 id=gb_36 href="http://www.youtube.com/results?sa=N&tab=t1">YouTube</a> <a onclick=gbar.logger.il(1,{t:5}); class=gb1 id=gb_5 href="http://news.google.com/nwshp?hl=en&tab=tn">News</a> <a onclick=gbar.logger.il(1,{t:23}); class=gb1 id=gb_23 href="https://mail.google.com/mail/?tab=tm">Gmail</a> <a onclick=gbar.logger.il(1,{t:25}); class=gb1 id=gb_25 href="https://drive.google.com/?tab=to">Drive</a> <a class=gb3 href="http://www.google.com/intl/en/options/" onclick="this.blur();gbar.tg(event);return !1" aria-haspopup=true><u>More</u> <small>&#9660;</small></a><div class=gbm id=gbi><a onclick=gbar.logger.il(1,{t:24}); class=gb2 id=gb_24 href="https://www.google.com/calendar?tab=tc">Calendar</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:51}); class=gb2 id=gb_51 href="http://translate.google.com/?hl=en&sa=N&tab=tT">Translate</a><a onclick=gbar.logger.il(1,{t:17}); class=gb2 id=gb_17 href="http://www.google.com/mobile/?hl=en&tab=tD">Mobile</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:10}); class=gb2 id=gb_10 href="http://www.google.com/search?hl=en&tbo=u&tbm=bks&source=og&sa=N&tab=tp">Books</a><a onclick=gbar.logger.il(1,{t:212}); class=gb2 id=gb_212 href="https://wallet.google.com/manage/?tab=ta">Wallet</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:6}); class=gb2 id=gb_6 href="http://www.google.com/search?hl=en&tbo=u&tbm=shop&source=og&sa=N&tab=tf">Shopping</a><a onclick=gbar.logger.il(1,{t:30}); class=gb2 id=gb_30 href="http://www.blogger.com/?tab=tj">Blogger</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:27}); class=gb2 id=gb_27 href="http://www.google.com/finance?sa=N&tab=te">Finance</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:31}); class=gb2 id=gb_31 href="https://plus.google.com/photos?sa=N&tab=tq">Photos</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:12}); class=gb2 id=gb_12 href="http://www.google.com/search?hl=en&tbo=u&tbm=vid&source=og&sa=N&tab=tv">Videos</a><div class=gb2><div class=gbd></div></div><a onclick=gbar.logger.il(1,{t:66}); href="http://www.google.com/intl/en/options/" class=gb2>Even more &raquo;</a></div></nobr></div><div id=guser width=100%><nobr><span id=gbn class=gbi></span><span id=gbf class=gbf></span><span id=gbe></span><a target=_top id=gb_70 href="https://www.google.com/accounts/Login?service=&continue=http://www.google.com/patents%3Fhl%3Den&hl=en" class=gb4>Sign in</a><div style="display: none"><div class=gbm id=gbd5 aria-owner=gbg5><div class=gbmc><ol id=gbom class=gbmcc></ol></div></div></div></nobr></div><div class=gbh style=left:0></div><div class=gbh style=right:0></div><div role="alert" style="position: absolute; left: 0; right: 0;"><a href="http://www.google.com/patents/us5916912?hl=en&amp;output=html_text" title="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."><img border="0" src="http://www.google.com/images/cleardot.gif"alt="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."></a></div><div id="guser"><nobr></nobr></div><div style="clear:both;"></div><div id="gb-top-search-box" class="gb-top-search-box-small gb-reset"><table><tr><td class="logo"><a href="http://www.google.com/patents" class="logo-link"><img class="logo-img" src="/intl/en/images/logos/google_logo_41.png" alt="Go to Google Books Home" height="41"/></a></td><td><form action="http://www.google.com/search" name="f" id="vheadf" method="get"><span id="hf"></span><input type="hidden" name="tbm" value="pts"/><input type="hidden" name="tbo" value="1"/><input type="hidden" name="hl" value="en"/><table><tr><td><div class="inputs"><table><tr><td><div class="text-input"><input type="text" name="q" id="vheadq" class="text" maxlength="2048" size="31" value="" title="Search Patents" accesskey="s" autocomplete="off"/><script>window._OC_autoDir &&window._OC_autoDir('vheadq', 'tia-vheadq');</script></div></td><td><div class="submit-input"><input name="btnG" class="submit" type="submit" value=""/></div></td></tr></table></div></td><td class="col-ext-links"><div class="ext-links"><a href="http://www.google.com/advanced_patent_search">&lt;nobr&gt;Advanced Patent Search&lt;/nobr&gt;</a></div></td></tr></table></form></td></tr></table></div><div class="kd-appbar"><h2 class="kd-appname"><a href="/patents">Patents</a></h2><div class="kd-buttonbar left" id="left-toolbar-buttons"><a id="appbar-write-review-link" href=""></a><a id="appbar-view-print-sample-link" href=""></a><a id="appbar-view-ebook-sample-link" href=""></a><a id="appbar-patents-prior-art-finder-link" href="https://www.google.com/patents/related/US5916912"></a><a id="appbar-patents-discuss-this-link" href="http://www.google.com/url?id=os5KBAABERAJ&amp;q=http://patents.stackexchange.com/redirect/google-patents%3Fpatent%3DUS5916912&amp;usg=AFQjCNFsucvZSXaVkbMdYa1LVLA2wwOVhw" data-is-grant="true"></a><a id="appbar-read-patent-link" href="//docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US5916912.pdf"></a><a id="appbar-download-pdf-link" href="//patentimages.storage.googleapis.com/pdfs/US5916912.pdf"></a></div><div class="kd-buttonbar right" id="right-toolbar-buttons"></div></div><div id="books-microdata" itemscope=""itemtype="http://schema.org/Book"itemid="http://www.google.com/patents/US5916912" style="display:none"><span itemprop="description">The metabolic rate of aged cells of a mammalian host is enhanced without a concomitant increase in metabolic production of reactive oxygen species by orally administering to the host an effective dosage of a carnitine, such as acetyl-L-carnitine, and a mitochondrially active antioxidant, such as lipoic...</span><span itemprop="url">http://www.google.com/patents/US5916912?utm_source=gb-gplus-share</span><span class="main-title" itemprop="name">Patent US5916912 - Orally administering to the host an effective dosage of a carnitine, such as acetyl-l-carnitine, and a mitochondrially active antioxidant, such as lipoic acid; restores mitochondiral functions; mitigation of indicia of aging</span><img itemprop="image" src="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"alt="Patent US5916912 - Orally administering to the host an effective dosage of a carnitine, such as acetyl-l-carnitine, and a mitochondrially active antioxidant, such as lipoic acid; restores mitochondiral functions; mitigation of indicia of aging" title="Patent US5916912 - Orally administering to the host an effective dosage of a carnitine, such as acetyl-l-carnitine, and a mitochondrially active antioxidant, such as lipoic acid; restores mitochondiral functions; mitigation of indicia of aging"></div><div style="display: none"><ol id="ofe-gear-menu-contents" class="gbmcc"><li class="gbe gbmtc"><a class="gbmt goog-menuitem-content" id="" href="http://www.google.com/advanced_patent_search">Advanced Patent Search</a></li></ol></div><table id="viewport_table" cellpadding="0" style="clear:both" cellspacing="0"><tr><td id="viewport_td"><div class=vertical_module_list_row><div id=intl_patents class=about_content><div id=intl_patents_v><table class="patent-bibdata"><tr><td class="patent-bibdata-heading">Publication number</td><td class="single-patent-bibdata">US5916912 A</td></tr><tr><td class="patent-bibdata-heading">Publication type</td><td class="single-patent-bibdata">Grant</td></tr><tr><td class="patent-bibdata-heading">Application number</td><td class="single-patent-bibdata">US 08/874,467</td></tr><tr><td class="patent-bibdata-heading">Publication date</td><td class="single-patent-bibdata">Jun 29, 1999</td></tr><tr><td class="patent-bibdata-heading">Filing date</td><td class="single-patent-bibdata">Jun 16, 1997</td></tr><tr><td class="patent-bibdata-heading">Priority date<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed."></span></td><td class="single-patent-bibdata">Jun 16, 1997</td></tr><tr><td class="patent-bibdata-heading">Fee status<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The fee status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status or dates listed."></span></td><td class="single-patent-bibdata">Paid</td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Also published as</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/CA2292497A1">CA2292497A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/CA2292497C">CA2292497C</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE69821123D1">DE69821123D1</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE69821123T2">DE69821123T2</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1014965A1">EP1014965A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1014965A4">EP1014965A4</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1014965B1">EP1014965B1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1413304A1">EP1413304A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/WO1998057627A1">WO1998057627A1</a></span></span></td></tr><tr class="patent-bibdata-list-row alternate-patent-number"><td class="patent-bibdata-heading">Publication number</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value">08874467, </span><span class="patent-bibdata-value">874467, </span><span class="patent-bibdata-value">US 5916912 A, </span><span class="patent-bibdata-value">US 5916912A, </span><span class="patent-bibdata-value">US-A-5916912, </span><span class="patent-bibdata-value">US5916912 A, </span><span class="patent-bibdata-value">US5916912A</span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Inventors</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Bruce+N.+Ames%22">Bruce N. Ames</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Tory+M.+Hagen%22">Tory M. Hagen</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Original Assignee</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22The+Regents+Of+The+University+Of+California%22">The Regents Of The University Of California</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Export Citation</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US5916912.bibtex">BiBTeX</a>, </span><span class="patent-bibdata-value"><a href="/patents/US5916912.enw">EndNote</a>, </span><span class="patent-bibdata-value"><a href="/patents/US5916912.ris">RefMan</a></span></span></td></tr><tr class="patent-internal-links"><td colspan=2><span class="patent-bibdata-value"><a href="#backward-citations">Patent Citations</a> (3),</span> <span class="patent-bibdata-value"><a href="#npl-citations">Non-Patent Citations</a> (2),</span> <span class="patent-bibdata-value"><a href="#forward-citations">Referenced by</a> (37),</span> <span class="patent-bibdata-value"><a href="#classifications">Classifications</a> (18),</span> <span class="patent-bibdata-value"><a href="#legal-events">Legal Events</a> (7)</span> </td></tr><tr><td colspan=2 class="patent-bibdata-external-link-spacer-top"></td></tr><tr class="patent-bibdata-external-link-spacer-bottom"></tr><tr><td colspan=2><span class="patent-bibdata-heading">External Links:&nbsp;</span><span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=os5KBAABERAJ&q=http://patft.uspto.gov/netacgi/nph-Parser%3FSect2%3DPTO1%26Sect2%3DHITOFF%26p%3D1%26u%3D/netahtml/PTO/search-bool.html%26r%3D1%26f%3DG%26l%3D50%26d%3DPALL%26RefSrch%3Dyes%26Query%3DPN/5916912&usg=AFQjCNFA3UJX-dD-PSPe3aURJXAZaKvuHA">USPTO</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=os5KBAABERAJ&q=http://assignments.uspto.gov/assignments/q%3Fdb%3Dpat%26pat%3D5916912&usg=AFQjCNEbS_ZQTZRMTq0tD2_5NZ1v0DzOrQ">USPTO Assignment</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=os5KBAABERAJ&q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DUS%26NR%3D5916912A%26KC%3DA%26FT%3DD&usg=AFQjCNFfAdqHzXPm0VSoIZWXfnXD6Reuxg">Espacenet</a></span></span></td></tr><tr class="patent-bibdata-group-spacer"></tr></table><div class="number-and-title"><span class="patent-title"><invention-title mxw-id="PT129711989" lang="EN" load-source="ifi">Orally administering to the host an effective dosage of a carnitine, such as acetyl-l-carnitine, and a mitochondrially active antioxidant, such as lipoic acid; restores mitochondiral functions; mitigation of indicia of aging</invention-title></span><br><span class="patent-number">US 5916912 A</span></div><div class="patent-section patent-abstract-section"><div class="patent-section-header"><span class="patent-section-title">Abstract</span></div><div class="patent-text"><abstract mxw-id="PA37924342" lang="EN" load-source="patent-office"> <div class="abstract">The metabolic rate of aged cells of a mammalian host is enhanced without a concomitant increase in metabolic production of reactive oxygen species by orally administering to the host an effective dosage of a carnitine, such as acetyl-L-carnitine, and a mitochondrially active antioxidant, such as lipoic acid.</div>
  </abstract></div></div><div class="patent-section patent-drawings-section"><div class="patent-section-header"><span class="patent-section-title">Images<span class="patent-section-count">(5)</span></span></div><div class="patent-drawings-body"><div class="patent-drawings-carousel"><div class="drawings"><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5916912-0.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5916912-0.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5916912-1.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5916912-1.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5916912-2.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5916912-2.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5916912-3.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5916912-3.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5916912-4.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5916912-4.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div></div></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img" alt="Previous page"src="/googlebooks/images/kennedy/page_left.png"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img" alt="Next page"src="/googlebooks/images/kennedy/page_right.png"width="21" height="21" /></div></div></div><div class="patent-post-drawings"></div><div class="patent-section patent-claims-section"><div class="patent-section-header"><span class="patent-section-title">Claims<span class="patent-section-count">(10)</span></span></div><div class="patent-text"><div mxw-id="PCLM5405736" lang="EN" load-source="patent-office" class="claims">
    <claim-statement>What is claimed is:</claim-statement> <div class="claim"> <div num="1" class="claim">
      <div class="claim-text">1. A method for increasing the metabolic rate of aged cells without a concomitant increase in metabolic production of reactive oxygen species, comprising orally administering to a mammalian host an effective dosage of at least about 10 mg/kg host/day of a carnitine and at least about 10 mg/kg host/day of a mitochondrially active antioxidant which physiologically comprises a metabolically reactive thiol group.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="2" class="claim">
      <div class="claim-text">2. The method of claim 1 wherein the carnitine is acetyl-L-carnitine.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="3" class="claim">
      <div class="claim-text">3. The method of claim 1 wherein the antioxidant comprises at least one of glutathione, N-acetyl cysteine and lipoic acid.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="4" class="claim">
      <div class="claim-text">4. The method of claim 1 wherein the antioxidant is lipoic acid.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="5" class="claim">
      <div class="claim-text">5. The method of claim 1 wherein the carnitine is acetyl-L-carnitine, the antioxidant is lipoic acid and the dosage is at least about 100 mg/kg host/day each.</div>
    </div>
    </div> <div class="claim"> <div num="6" class="claim">
      <div class="claim-text">6. An orally administratable dry unit dosage comprising at least about 250 mg of a carnitine and at least about 250 mg of a mitochondrially active antioxidant which physiologically comprises a metabolically reactive thiol group.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="7" class="claim">
      <div class="claim-text">7. The dosage of claim 6 wherein the carnitine is acetyl-L-carnitine.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="8" class="claim">
      <div class="claim-text">8. The dosage of claim 6 wherein the antioxidant comprises at least one of glutathione, N-acetyl cysteine and lipoic acid.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="9" class="claim">
      <div class="claim-text">9. The dosage of claim 6 wherein the antioxidant is lipoic acid.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="10" class="claim">
      <div class="claim-text">10. The dosage of claim 6 wherein the carnitine is acetyl-L-carnitine and the antioxidant is lipoic acid.</div>
    </div>
  </div> </div></div></div><div class="patent-section patent-description-section"><div class="patent-section-header"><span class="patent-section-title">Description</span></div><div class="patent-text"><div mxw-id="PDES67297691" lang="EN" load-source="patent-office" class="description">
    <p>This invention was made with Government support under Grant (Contract) Nos.: CA39910 and ES01896 awarded by the National Institutes of Health to Professor Bruce Ames. The Government has certain rights to this invention.</p>
    <heading>INTRODUCTION</heading> <p>1. Field of the Invention</p>
    <p>The field of the invention is dietary compositions and methods for modifying both cellular metabolism and the metabolic production of reactive oxygen species.</p>
    <p>2. Background of the Invention</p>
    <p>Numerous lines of evidence suggest that the organelles of cellular respiration, the mitochondria, decay with cellular aging (Shigenaga et al. 1994, PNAS 91, 10771). Unfortunately, the study of mitochondrial aging has been hampered because mitochondria isolated from older cells and host animals are fragile and heterogeneous. Hence the interpretation of any results is suspect as about half the mitochondria lyse during isolation. Our laboratory recently described a new method for studying mitochondria in hepatocytes from old animals that avoids this problem (Hagen et al. 1997, PNAS 94, 3064-3069). We found that mitochondria from older animals are not only more fragile, but have about half the level of cardiolipin, a key lipid unique to mitochondria, without which they can not maintain a high membrane potential. Furthermore, Hagen et al. show that in hepatocytes from older animals, the mitochondria are lower in membrane potential and leak out more toxic oxidants.</p>
    <heading>SUMMARY OF THE INVENTION</heading> <p>We have found that carnitine (a normal mitochondrial metabolite used to transport fatty acids into the mitochondria as fuel) and carnitine derivatives, when put into the drinking water of old animals, restore the cardiolipin and membrane potential of their mitochondria. At the same time, the carnitines increase the flux of reactive oxygen species from the mitochondria. We have found that we can specifically alleviate this enhanced flux with mitochondrially active antioxidants, such as lipoic acid. The two reagents given to old animals, restored all three mitochondrial functions and reversed several gross indicia of aging, including activity, muscle tone, coat appearance and kidney morphology.</p>
    <p>Carnitine and carnitine derivatives have been used as metabolites in animal husbandry and for human diet and therapy. U.S. Pat. No. 5,362,753 (Method of increasing the hatchability of eggs by feeding hens carnitine); U.S. Pat. No. 4,687,782 (Nutritional composition for enhancing skeletal muscle adaptation to exercise training); U.S. Pat. No. 5,030,458 (Method for preventing diet-induced carnitine deficiency in domesticated dogs and cats); U.S. Pat. No. 5,030,657 (L-carnitine supplemented catfish diet); U.S. Pat. No. 4,343,816 (Pharmaceutical composition comprising an acyl-carnitine, for treating peripheral vascular diseases); U.S. Pat. No. 5,560,928 (Nutritional and/or dietary composition and method of using the same); U.S. Pat. No. 5,504,072 (Enteral nutritional composition having balanced amino acid profile); U.S. Pat. No. 5,391,550 (Compositions of matter and methods for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair); U.S. Pat. No. 5,240,961 (Method of treating reduced insulin-like growth factor and bone loss associated with aging); etc.</p>
    <p>Similarly, mitochondrially active antioxidants including vitamins (especially C, E, B and D), glutathione, N-acetyl cysteine, lipoic acid, etc., have been used variously as human nutritional supplements and in dietary prophylaxis and therapy. For example, applications of lipoic acid have include U.S. Pat. No. 5,607,980 (Topical compositions having improved skin); U.S. Pat. No. 5,472,698 (Composition for enhancing lipid production in skin); U.S. Pat. No. 5,292,538 (Improved sustained energy and anabolic composition and method of making); U.S. Pat. No. 5,536,645 (Nutritive medium for the culture of microorganisms); U.S. Pat. No. 5,326,699 (Serum-free medium for culturing animal cells); etc.</p>
    <p>These reagents, however, have never been administered in the combinations and dosages necessary to effect enhanced metabolic processes and simultaneously alleviate the resultant increase in oxidative stress. In general, the disclosed methods involve increasing the metabolic rate of aged cells of a mammalian host without a concomitant increase in metabolic production of reactive oxygen species by orally administering to the host an effective dosage of at least about 10 mg/kg host/day of a carnitine and at least about 10 mg/kg host/day of a mitochondrially active antioxidant. In preferred embodiments, the carnitine is acetyl-L-carnitine and the antioxidant comprises a metabolically reactive thiol group and is preferably lipoic acid. The invention also provides orally administratable unit dosages comprising at least about 250 mg/kg host/day of a carnitine and at least about 250 mg/kg host/day of a mitochondrially active antioxidant.</p>
    <heading>DETAILED DESCRIPTION OF SPECIFIC EMBODIMENTS OF THE INVENTION</heading> <p>Methods for making and preparing carnitine and active carnitine derivatives are known in the art, e.g. U.S. Pat No.: 4,766,222 (Novel class of acyl-derivatives of carnitine process for preparing same and therapeutic use thereof); U.S. Pat. No. 4,673,534 (Carnitine salts particularly suitable for oral use); U.S. Pat. No. 4,743,621 (Ester of acetyl carnitine, processes for its preparation and pharmaceutical compositions containing it); U.S. Pat. No. 4,593,043 (Mercapto acyl-carnitines and pharmaceutical compositions containing same); U.S. Pat. No. 4,590,209 (Alkoxy-acyl carnitines and pharmaceutical compositions containing same); U.S. Pat. No. 4,567,200 (Esters of mercapto acyl-carnitines and pharmaceutical compositions containing same); U.S. Pat. No. 4,032,641 (Nicotinoyl carnitine derivatives); U.S. Pat. No. 4,551,477 (Esters of alkoxy-acylderivatives of carnitine and pharmaceutical compositions containing same); U.S. Pat. No. 4,401,827 (Novel acyl-derivatives of carnitine and process for their preparation); U.S. Pat. No. 5,260,464 (Carnitine derivatives, process for their preparation, and their use in human therapy); U.S. Pat. No. 4,859,698 (Novel class of acyl-derivatives of carnitine, process for preparing same and therapeutic use thereof); U.S. Pat. No. 4,692,543 (Optically-active di- 3-chloro-2-oxy-propyltrimethylammonium!-tartrate); U.S. Pat. No. 5,258,552 (N-alkylamides of d(+)-carnitine having antibacterial activity, process for their preparation and pharmaceutical and cosmetic compositions containing same); etc.</p>
    <p>Similarly, a wide variety of mitochondrially active antioxidants (i.e. antioxidants which reduce the metabolic production of reactive oxygen species, as measured, for example by the oxidant production assay described below) and their methods of formulation, synthesis and production are known. Generally these include physiologically reactive thiols, preferably physiologically reactive sulfhydryl group containing compounds. Exemplary antioxidants include glutathione, NAC, lipoic acid, their derivatives, etc. For example, lipoic acid derivatives and their methods of production are well described, e.g. U.S. Pat. No. 5,621,117 (Method for the racemization of enantiomers of α-lipoic acid); U.S. Pat. No. 5,489,694 (Preparation of R/S-γ-lipoic acid or R/S-α-lipoic acid); U.S. Pat. No. 5,463,093 (Palladium complexes and methods for using same in the treatment of tumors or Psoriasis); U.S. Pat. No. 5,334,612 (Pharmaceutical compositions containing as active substance sulphur-containing carboxylic acids and their use in combating retroviruses); U.S. Pat. No. 4,390,620 (Method and composition for the detection and study of cellular activity or the like and means for applying such method); U.S. Pat. No. 5,118,505 (Combination preparation for the treatment of nerve cell and nerve fibre diseases and injury); U.S. Pat. No. 4,767,704 (Protein-free culture medium), etc. In addition, we have found the R-enantiomeric form of lipoic especially suitable for preferential mitochondrial targeting.</p>
    <p>Convenient assays for the requisite bioactivities are described above or in the references cited herein. For example, cardiolipin content is readily assayed as referenced in Guan, Z. Z., Soderberg, M., Sindelar, P., and Edlund, C. Content and Fatty Acid Composition of Cardiolipin in the Brain of Patients with Alzheimer's Disease. Neurochem. Int. 25: 295-300, 1994 and oxidant production (DCFH) may be assayed as described by LeBel, C. P., Ischiropoulos, H., and Bondy, S. C. Evaluation of the Probe 2',7'-Dichlorofluorescin as an Indicator of Reactive Oxygen Species Formation and Oxidative Stress. Chem. Res. Toxicol. 5: 227-231, 1992. Assays for parameters of aging such as host activity and behavior such as grooming, sexual activity, dominance, etc., coat condition, wound repair, including molecular lesions, muscle strength and tone, kidney appearance and function, etc. are similarly well known in the art.</p>
    <p>The invention provides administratively convenient formulations of the compositions including dosage units incorporated into a variety of containers. Dosages of the carnitine and antioxidant are administered orally in the range of about 1 mg/kg to about 1 g/kg, preferably in the range of about 10 mg/kg to about 500 mg/kg more preferably in the range of about 20 mg/kg to about 200 mg/kg of body weight per day, although variations will necessarily occur depending on the formulation, host, etc. Convenient unit dosage containers and/or formulations include tablets, capsules, lozenges, troches, hard candies, powders, metered sprays, creams, suppositories, etc. The compositions may be combined with a pharmaceutically acceptable excipient such as gelatin, an oil, etc. and/or other pharmaceutically active agent(s). For example, the compositions may be advantageously combined and/or used in combination with other therapeutic or prophylactic agents, different from the subject compounds. In many instances, administration in conjunction with the subject compositions enhances the efficacy of such agents. For example, the compounds may be advantageously used in conjunction with other antioxidants, free radical scavengers; etc.; and mixtures thereof, see e.g. Goodman &amp; Gilman's The Pharmacological Basis of Therapeutics, 9<sup>th</sup> Ed., 1996, McGraw-Hill. In another embodiment, the invention provides the subject compounds in the form of one or more pro-drugs, which can be metabolically converted to the subject compounds by the recipient host. A wide variety of pro-drug formulations are known in the art.</p>
    <p>The following examples are offered by way of illustration and not by way of limitation.</p>
    <heading>EXAMPLES</heading> <p>Formulation 1. 250 mg pharmaceutical grade dry acetyl-L-carnitine and 250 mg pharmaceutical grade dry lipoic acid are administered orally 4× daily in 500 mg gelatin capsules.</p>
    <p>Formulation 2. 500 mg pharmaceutical grade dry acetyl-L-carnitine and 300 mg pharmaceutical grade dry N-acetyl cysteine are administered orally 4× daily in 800 mg gelatin capsules.</p>
    <p>Formulation 3. 1% w/v of each pharmaceutical grade acetyl-L-carnitine and pharmaceutical grade glutathione are administered orally in a 2% glucose solution to 0.2 and 0.1 g/kg/day total dosage.</p>
    <p>Animal data reveal treated host cell mitochondria demonstrate enhanced levels of cardiolipin and membrane potential, reduced production of reactive oxygen species, and mitigation of indicia of aging, including activity, muscle tone, coat appearance and kidney morphology.</p>
    <p>All publications and patent applications cited in this specification are herein incorporated by reference as if each individual publication or patent application were specifically and individually indicated to be incorporated by reference. Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it will be readily apparent to those of ordinary skill in the art in light of the teachings of this invention that certain changes and modifications may be made thereto without departing from the spirit or scope of the appended claims.</p>
    </div></div></div><div class="patent-section patent-tabular-section"><a id="backward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Cited Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4599232">US4599232</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 9, 1984</td><td class="patent-data-table-td patent-date-value">Jul 8, 1986</td><td class="patent-data-table-td ">Sigma Tau Industrie Faramaceutiche Riunite S.P.A.</td><td class="patent-data-table-td ">Coenzyme q/o and carnitine</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5292538">US5292538</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jul 22, 1992</td><td class="patent-data-table-td patent-date-value">Mar 8, 1994</td><td class="patent-data-table-td ">Metagenics, Inc.</td><td class="patent-data-table-td ">Fructose, glucose, protein blend</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5560928">US5560928</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 23, 1995</td><td class="patent-data-table-td patent-date-value">Oct 1, 1996</td><td class="patent-data-table-td ">Defelice; Stephen L.</td><td class="patent-data-table-td ">Nutritional and/or dietary composition and method of using the same</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="npl-citations"></a><div class="patent-section-header"><span class="patent-section-title">Non-Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th colspan="3"class="patent-data-table-th">Reference</th></tr></thead><tr><td class="patent-data-table-td ">1</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Medical Hypotheses, McCarty; vol. 7, pp. 520 521, 1981.</td></tr><tr><td class="patent-data-table-td ">2</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Medical Hypotheses, McCarty; vol. 7, pp. 520-521, 1981.</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="forward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Referenced by</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Citing Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6335361">US6335361</a></td><td class="patent-data-table-td patent-date-value">Nov 2, 2000</td><td class="patent-data-table-td patent-date-value">Jan 1, 2002</td><td class="patent-data-table-td ">Juvenon Inc.</td><td class="patent-data-table-td ">Method of treating benign forgetfulness</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6365622">US6365622</a></td><td class="patent-data-table-td patent-date-value">Aug 19, 1999</td><td class="patent-data-table-td patent-date-value">Apr 2, 2002</td><td class="patent-data-table-td ">Sigma-Tau Healthscience S.P.A.</td><td class="patent-data-table-td ">Antioxidant composition comprising acetyl L-carnitine and α-lipoic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6476010">US6476010</a></td><td class="patent-data-table-td patent-date-value">Mar 1, 2001</td><td class="patent-data-table-td patent-date-value">Nov 5, 2002</td><td class="patent-data-table-td ">Hill&#39;s Pet Nutrition</td><td class="patent-data-table-td ">Orally administering to a post-menopausal woman a fat soluble vitamin and a fat soluble vitamin absorption increasing effective amount of l-carnitine or salts</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6479069">US6479069</a></td><td class="patent-data-table-td patent-date-value">Sep 8, 2000</td><td class="patent-data-table-td patent-date-value">Nov 12, 2002</td><td class="patent-data-table-td ">Juvenon, Inc.</td><td class="patent-data-table-td ">Containing lipoic acid, a carnitine, coenzyme q10, creatine, carbohydrates and fats</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6562869">US6562869</a></td><td class="patent-data-table-td patent-date-value">Nov 27, 2001</td><td class="patent-data-table-td patent-date-value">May 13, 2003</td><td class="patent-data-table-td ">Juvenon, Inc.</td><td class="patent-data-table-td ">A gelatin having a composition consisting essentially of: alpha -lipoic acid in the amount about 0.025 grams to about 1. 5 grams; acetyl-L-carnitine in the amount of about 0.01 grams to about 3 grams; creatine in the amount and a carbohydrate</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6573299">US6573299</a></td><td class="patent-data-table-td patent-date-value">Sep 20, 1999</td><td class="patent-data-table-td patent-date-value">Jun 3, 2003</td><td class="patent-data-table-td ">Advanced Medical Instruments</td><td class="patent-data-table-td ">Method and compositions for treatment of the aging eye</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6914071">US6914071</a></td><td class="patent-data-table-td patent-date-value">Oct 16, 2001</td><td class="patent-data-table-td patent-date-value">Jul 5, 2005</td><td class="patent-data-table-td ">Colgate-Palmolive Company</td><td class="patent-data-table-td ">Antioxidant containing composition and method</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7030154">US7030154</a></td><td class="patent-data-table-td patent-date-value">Jun 5, 2003</td><td class="patent-data-table-td patent-date-value">Apr 18, 2006</td><td class="patent-data-table-td ">Juvenon, Inc.</td><td class="patent-data-table-td ">Stability of lipoic acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7235582">US7235582</a></td><td class="patent-data-table-td patent-date-value">Nov 3, 2003</td><td class="patent-data-table-td patent-date-value">Jun 26, 2007</td><td class="patent-data-table-td ">Laboratorio Chimico Internazionale S.P.A.</td><td class="patent-data-table-td ">Basic salt of thioctic acid with L-carnitine</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7282225">US7282225</a></td><td class="patent-data-table-td patent-date-value">Sep 27, 2006</td><td class="patent-data-table-td patent-date-value">Oct 16, 2007</td><td class="patent-data-table-td ">Occular Technologies, Inc.</td><td class="patent-data-table-td ">Composition and methods for improving retinal health</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7540852">US7540852</a></td><td class="patent-data-table-td patent-date-value">Aug 26, 2004</td><td class="patent-data-table-td patent-date-value">Jun 2, 2009</td><td class="patent-data-table-td ">Flowcardia, Inc.</td><td class="patent-data-table-td ">Ultrasound catheter devices and methods</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7951847">US7951847</a></td><td class="patent-data-table-td patent-date-value">Mar 7, 2008</td><td class="patent-data-table-td patent-date-value">May 31, 2011</td><td class="patent-data-table-td ">K-Pax Vitamins, Inc.</td><td class="patent-data-table-td ">Comprising an optimal combination of at least one vitamin antioxidant, at least one mineral antioxidant and a highly saturable amount of at least three high potency antioxidants; promotes healing process of physiological disorders or diseases</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8148325">US8148325</a></td><td class="patent-data-table-td patent-date-value">Dec 30, 2005</td><td class="patent-data-table-td patent-date-value">Apr 3, 2012</td><td class="patent-data-table-td ">Hill&#39;s Pet Nutrition, Inc.</td><td class="patent-data-table-td ">Improved alertness, vitality, cartilage protection, maintenance of muscle mass, and skin and pelage quality; feeding the cat, dog or horse a food with at least 9% protein, 5% fat, and 0.05% of at least one omega-3 polyunsaturated fatty acid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8173618">US8173618</a></td><td class="patent-data-table-td patent-date-value">Jul 23, 2004</td><td class="patent-data-table-td patent-date-value">May 8, 2012</td><td class="patent-data-table-td ">University Of Massachusetts</td><td class="patent-data-table-td ">Nutraceuticals including folate, vitamin E, and acetyl-L-carnitine, and pharmaceuticals including 3-deaza-adenosine, N-acetyl-L-cysteine, and S-adenosylmethionine; Alzheimer&#39;s disease; amyotrophic lateral sclerosis (ALS)</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8252742">US8252742</a></td><td class="patent-data-table-td patent-date-value">Jul 18, 2008</td><td class="patent-data-table-td patent-date-value">Aug 28, 2012</td><td class="patent-data-table-td ">Hill&#39;s Pet Nutrition, Inc.</td><td class="patent-data-table-td ">Methods for enhancing the quality of life of a senior animal</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8263646">US8263646</a></td><td class="patent-data-table-td patent-date-value">May 22, 2009</td><td class="patent-data-table-td patent-date-value">Sep 11, 2012</td><td class="patent-data-table-td ">Hill&#39;s Pet Nutrition, Inc.</td><td class="patent-data-table-td ">Methods for the treatment of kidney disease</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8361512">US8361512</a></td><td class="patent-data-table-td patent-date-value">May 27, 2011</td><td class="patent-data-table-td patent-date-value">Jan 29, 2013</td><td class="patent-data-table-td ">K-Pax Vitamins, Inc.</td><td class="patent-data-table-td ">Nutrient compositions and methods for enhanced effectiveness of the immune system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8492432">US8492432</a></td><td class="patent-data-table-td patent-date-value">Aug 17, 2006</td><td class="patent-data-table-td patent-date-value">Jul 23, 2013</td><td class="patent-data-table-td ">Hill&#39;s Pet Nutrition, Inc.</td><td class="patent-data-table-td ">Mixture of antioxidants and mitochondrial cofactors; kidney disease or for improving kidney function.</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8535708">US8535708</a></td><td class="patent-data-table-td patent-date-value">Dec 29, 2005</td><td class="patent-data-table-td patent-date-value">Sep 17, 2013</td><td class="patent-data-table-td ">Hill&#39;s Pet Nutrition, Inc.</td><td class="patent-data-table-td ">Methods for inhibiting a decline in learning and/or memory in animals</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8592478">US8592478</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 16, 2005</td><td class="patent-data-table-td patent-date-value">Nov 26, 2013</td><td class="patent-data-table-td ">Hill&#39;s Pet Nutrition, Inc.</td><td class="patent-data-table-td ">Antioxidant-containing food composition</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8592479">US8592479</a></td><td class="patent-data-table-td patent-date-value">Dec 16, 2008</td><td class="patent-data-table-td patent-date-value">Nov 26, 2013</td><td class="patent-data-table-td ">Hill&#39;s Pet Nutrition, Inc.</td><td class="patent-data-table-td ">Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8597640">US8597640</a></td><td class="patent-data-table-td patent-date-value">Apr 4, 2008</td><td class="patent-data-table-td patent-date-value">Dec 3, 2013</td><td class="patent-data-table-td ">University Of Massachusetts Lowell</td><td class="patent-data-table-td ">Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer&#39;s disease and normal aging</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8669211">US8669211</a></td><td class="patent-data-table-td patent-date-value">Jul 24, 2012</td><td class="patent-data-table-td patent-date-value">Mar 11, 2014</td><td class="patent-data-table-td ">Hill&#39;s Pet Nutrition, Inc.</td><td class="patent-data-table-td ">Methods for measuring enhancement in the quality of life of an animal</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8669282">US8669282</a></td><td class="patent-data-table-td patent-date-value">Dec 30, 2008</td><td class="patent-data-table-td patent-date-value">Mar 11, 2014</td><td class="patent-data-table-td ">Hill&#39;s Pet Nutrition, Inc.</td><td class="patent-data-table-td ">Companion animal compositions including lipoic acid and methods of use thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8722112">US8722112</a></td><td class="patent-data-table-td patent-date-value">Jul 14, 2006</td><td class="patent-data-table-td patent-date-value">May 13, 2014</td><td class="patent-data-table-td ">Hill&#39;s Pet Nutrition, Inc.</td><td class="patent-data-table-td ">Method for prolonging the life of animals</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8759283">US8759283</a></td><td class="patent-data-table-td patent-date-value">Sep 24, 2013</td><td class="patent-data-table-td patent-date-value">Jun 24, 2014</td><td class="patent-data-table-td ">Hill&#39;s Pet Nutrition, Inc.</td><td class="patent-data-table-td ">Methods for detecting mRNA and/or protein levels of gene in a biological sample</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20110274808">US20110274808</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 29, 2009</td><td class="patent-data-table-td patent-date-value">Nov 10, 2011</td><td class="patent-data-table-td ">Hill&#39;s Pet Nutrition, Inc.</td><td class="patent-data-table-td ">Methods for increasing the palatability of companion animal food compositions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20130224281">US20130224281</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 4, 2012</td><td class="patent-data-table-td patent-date-value">Aug 29, 2013</td><td class="patent-data-table-td ">United States Of America As Represented By The Administrator Of The National Aeronautics &amp; Space</td><td class="patent-data-table-td ">Method and composition for ameliorating the effects for a subject exposed to radiation or other sources of oxidative stress</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/CN100567287C?cl=en">CN100567287C</a></td><td class="patent-data-table-td patent-date-value">Oct 31, 2003</td><td class="patent-data-table-td patent-date-value">Dec 9, 2009</td><td class="patent-data-table-td ">国际化学实验室股份公司</td><td class="patent-data-table-td ">Basic salt of thioctic acid and L-carnitine</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/CN101022793B?cl=en">CN101022793B</a></td><td class="patent-data-table-td patent-date-value">Jun 23, 2005</td><td class="patent-data-table-td patent-date-value">May 11, 2011</td><td class="patent-data-table-td ">美国益力斯林公司</td><td class="patent-data-table-td ">Dietary compositions for enhancing metabolism and reducing reactive oxygen species</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2000011968A1?cl=en">WO2000011968A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 19, 1999</td><td class="patent-data-table-td patent-date-value">Mar 9, 2000</td><td class="patent-data-table-td ">Claudio Cavazza</td><td class="patent-data-table-td ">ANTIOXIDANT COMPOSITION COMPRISING ACETYL L-CARNITINE AND α-LIPOIC ACID</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2001058271A1?cl=en">WO2001058271A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 25, 2001</td><td class="patent-data-table-td patent-date-value">Aug 16, 2001</td><td class="patent-data-table-td ">Juvenon Inc</td><td class="patent-data-table-td ">Nutritional supplements for aged pets</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2002071874A2?cl=en">WO2002071874A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 7, 2002</td><td class="patent-data-table-td patent-date-value">Sep 19, 2002</td><td class="patent-data-table-td ">Nestle Sa</td><td class="patent-data-table-td ">Composition improving age-related physiological deficits and increasing longevity</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2004037011A1?cl=en">WO2004037011A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 11, 2003</td><td class="patent-data-table-td patent-date-value">May 6, 2004</td><td class="patent-data-table-td ">Nestec Sa</td><td class="patent-data-table-td ">Senior feline food</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2004094403A1?cl=en">WO2004094403A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 31, 2003</td><td class="patent-data-table-td patent-date-value">Nov 4, 2004</td><td class="patent-data-table-td ">Angelis Bruno De</td><td class="patent-data-table-td ">Basic salt of thioctic acid with l-carnitine</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2006012267A1?cl=en">WO2006012267A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 23, 2005</td><td class="patent-data-table-td patent-date-value">Feb 2, 2006</td><td class="patent-data-table-td ">Elixirin Corp</td><td class="patent-data-table-td ">Dietary compositions for enhancing metabolism and reducing reactive oxygen species</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2010111218A1?cl=en">WO2010111218A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 23, 2010</td><td class="patent-data-table-td patent-date-value">Sep 30, 2010</td><td class="patent-data-table-td ">Lucy Tyler</td><td class="patent-data-table-td ">Method for increasing energy in hiv and/or aids patients</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="classifications"></a><div class="patent-section-header"><span class="patent-section-title">Classifications</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th"> </th><th class="patent-data-table-th"> </th></tr></thead><tr><td class="patent-data-table-td ">U.S. Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=os5KBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S440000">514/440</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=os5KBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc514/defs514.htm&usg=AFQjCNG3QPK1Vhbpe6jO1mfvD3pMcfCuxA#C514S561000">514/561</a></span></td></tr><tr><td class="patent-data-table-td ">International Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=os5KBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031385000">A61K31/385</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=os5KBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031325000">A61K31/325</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=os5KBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61P0043000000">A61P43/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=os5KBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031205000">A61K31/205</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=os5KBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0045060000">A61K45/06</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=os5KBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0031221000">A61K31/221</a></span></td></tr><tr><td class="patent-data-table-td ">Cooperative Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=os5KBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K31/221">A61K31/221</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=os5KBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K45/06">A61K45/06</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=os5KBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K31/205">A61K31/205</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=os5KBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K31/385">A61K31/385</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=os5KBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K31/325">A61K31/325</a></span></td></tr><tr><td class="patent-data-table-td ">European Classification</td><td class="patent-data-table-td "><span class="nested-value">A61K31/221</span>, <span class="nested-value">A61K31/325</span>, <span class="nested-value">A61K31/205</span>, <span class="nested-value">A61K31/385</span>, <span class="nested-value">A61K45/06</span></td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="legal-events"></a><div class="patent-section-header"><span class="patent-section-title">Legal Events</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Date</th><th class="patent-data-table-th">Code</th><th class="patent-data-table-th">Event</th><th class="patent-data-table-th">Description</th></tr></thead><tr><td class="patent-data-table-td patent-date-value">Mar 20, 2012</td><td class="patent-data-table-td ">B1</td><td class="patent-data-table-td ">Reexamination certificate first reexamination</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">THE PATENTABILITY OF CLAIM 5 IS CONFIRMED. CLAIMS 1-4 AND 6-10 ARE CANCELLED. NEW CLAIMS 11-16 ARE ADDED AND DETERMINED TO BE PATENTABLE.</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Dec 29, 2010</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">12</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Dec 29, 2006</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">8</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Aug 30, 2005</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20050713</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Dec 6, 2002</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">4</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Sep 9, 1999</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">NATIONAL INSTITUTES OF HEALTH, THE, MARYLAND</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">CONFIRMATORY LICENSE;ASSIGNOR:CALIFORNIA, UNIVERSITY OF;REEL/FRAME:010221/0823</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">19970729</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jan 12, 1998</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">CALIFORNIA, REGENTS OF THE UNIVERSITY OF, CALIFORN</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:AMES, BRUCE N.;HAGEN, TORY M.;REEL/FRAME:009073/0794</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">19980106</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">REGENTS OF THE UNIVERSITY OF CALIFORNIA, CALIFORNI</span></div></td></tr></table><div class="patent-section-footer"></div></div><div class="modal-dialog" id="patent-images-lightbox"><div class="patent-lightbox-controls"><div class="patent-lightbox-rotate-controls"><div class="patent-lightbox-rotation-text">Rotate</div><div class="rotate-icon rotate-ccw-icon"></div><div class="rotate-icon rotate-cw-icon"></div></div><div class="patent-lightbox-index-counter"></div><a class="patent-lightbox-fullsize-link" target="_blank">Original Image</a><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_right.png" alt="Next page"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_left.png" alt="Previous page"width="21" height="21" /></div></div><div class="modal-dialog-content"><div class="patent-lightbox-image-holder"><div class="patent-lightbox-placeholder"></div></div></div></div><script>_OC_initPatentsAtb({image_not_available_html: " Image not available"});</script></div></div></div></td></tr></table><script>(function() {var href = window.location.href;if (href.indexOf('?') !== -1) {var parameters = href.split('?')[1].split('&');for (var i = 0; i < parameters.length; i++) {var param = parameters[i].split('=');if (param[0] == 'focus') {var elem = document.getElementById(param[1]);if (elem) {elem.focus();}}}}})();</script><script>_OC_addFlags({LockSrc:"/books/javascript/lock_8a2b04e7bf975d5171d8e4c0b6365c7a.js", Host:"http://www.google.com/", IsBooksRentalEnabled:1, IsWebstoreDisplayCaseEnabled:1, IsObfuscationEnabled:1, IsBrowsingHistoryEnabled:1, IsWebReaderSvgEnabled:0, IsGeoLayerEnabled:1, IsImageModeNotesEnabled:1, IsCopyMenuItemEnabled:1, IsGiftingEnabled:0, IsWebReaderUniversalPaginatorEnabled:0, IsOfflineBubbleEnabled:1, IsReaderEnabledForPlayRequests:1, IsFutureOnSaleVolumesEnabled:1, IsOfflineRestrictedCopyEnabled:1, IsBooksUnifiedLeftNavEnabled:1, IsRestrictedCopyEnabled:1, IsZipitFolderCollectionEnabled:1, IsEndOfSampleRecommendationsEnabled:1, IsRatingsOnBookcardsEnabled:1, IsAdsDisabled:0, IsIframePageDisplayEnabled:0, IsEmbeddedMediaEnabled:1, IsImageModeAnnotationsEnabled:1, IsMyLibraryGooglePlusEnabled:1, IsImagePageProviderEnabled:0, IsBookcardListPriceSmall:0, IsInternalUser:0, IsBooksShareButtonEnabled:0, IsPreOrdersEnabled:0, IsDisabledRandomBookshelves:0, WebstoreDisplayCasePosition:3});_OC_Run({"enable_p13n":false,"add_vol_to_collection_base_url":"http://www.google.com/patents?op=add\u0026sig=ACfU3U3-uMFi6M-TiToOxX0beB5W44MnFQ\u0026id=os5KBAABERAJ","remove_vol_from_collection_base_url":"http://www.google.com/patents?op=remove\u0026sig=ACfU3U2_HUe_1oNjc5CkKi-nbR6pCNlBfA\u0026id=os5KBAABERAJ","logged_in":false,"p13n_save_user_settings_url":"http://www.google.com/patents?op=edit_user_settings\u0026sig=ACfU3U3K2cVnYjmMtTFGkCdQWRMsuCsRGQ","is_cobrand":false,"sign_in_url":"https://www.google.com/accounts/Login?service=\u0026continue=http://www.google.com/patents%3Fhl%3Den\u0026hl=en","is_play_enabled":true}, {"volume_id":"","is_ebook":true,"volumeresult":{"has_flowing_text":false,"has_scanned_text":true,"can_download_pdf":false,"can_download_epub":false,"is_pdf_drm_enabled":false,"is_epub_drm_enabled":false,"download_pdf_url":"http://www.google.com/patents/download/Orally_administering_to_the_host_an_effe.pdf?id=os5KBAABERAJ\u0026output=pdf\u0026sig=ACfU3U3kDpy4PaV_uR43ZlBW98uzfon7XQ"},"sample_url":"http://www.google.com/patents/reader?id=os5KBAABERAJ\u0026printsec=frontcover\u0026output=reader\u0026source=gbs_atb_hover","is_browsable":true,"is_public_domain":true}, {});</script><div id="footer_table" style="font-size:83%;text-align:center;position:relative;top:20px;height:4.5em;margin-top:2em"><div style="margin-bottom:8px"><a href=http://www.google.com/><nobr>Google&nbsp;Home</nobr></a> - <a href=//www.google.com/patents/sitemap/><nobr>Sitemap</nobr></a> - <a href=http://www.google.com/googlebooks/uspto.html><nobr>USPTO Bulk Downloads</nobr></a> - <a href=/intl/en/privacy/><nobr>Privacy Policy</nobr></a> - <a href=/intl/en/policies/terms/><nobr>Terms of Service</nobr></a> - <a href=https://support.google.com/faqs/answer/2539193?hl=en><nobr>About Google Patents</nobr></a> - <a href="http://www.google.com/tools/feedback/intl/en/error.html" onclick="try{_OC_startFeedback({productId: '72792',locale: 'en'});return false;}catch(e){}"><nobr>Send Feedback</nobr></a></div><span>Data provided by IFI CLAIMS Patent Services</span><br><span >&copy;2012 Google</span></div> <script type="text/javascript">var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));</script><script type="text/javascript">var pageTracker = _gat._getTracker("UA-27188110-1");pageTracker._setCookiePath("/patents/");pageTracker._trackPageview();</script> </body></html>